Status:
UNKNOWN
Immune Profile of Acute VKH Patients PBMC
Lead Sponsor:
Aier School of Ophthalmology, Central South University
Conditions:
VKH Syndrome
Eligibility:
All Genders
18-50 years
Brief Summary
The investigators will collect blood samples of different courses of VKH patients for investigating immune profile, observe major immune cells number ,functional and membrane molecular changes in the ...
Eligibility Criteria
Inclusion
- Acute VKH patients, meet a criterion of VKH, no recurrence.
- Age range from 18 to 50 years old.
Exclusion
- Patients with Severe Cardiovascular and Cerebrovascular Diseases
- Patients allergic to steroid or contrast agents;
- A history of ocular trauma or intraocular surgery within 3 months; Vaccinated; History of infectious diseases
- having a history of heredity, immune system correlation, neuroendocrine and digestive system diseases
- Patients who take health care products for a long time and have heavy alcohol and tobacco addiction.
Key Trial Info
Start Date :
July 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 7 2022
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04025476
Start Date
July 20 2019
End Date
July 7 2022
Last Update
July 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Aier eye hospital
Wuhan, Hubei, China, 430064